Clinical Trials Directory

Trials / Completed

CompletedNCT05837962

Nursing Intervention for Knowledge and Self-care Behaviors in the Face of Hypertensive Disorders of Pregnancy

Feasibility and Acceptability of the Nursing Intervention "EducaTHE" to Improve Knowledge and Self-care Behaviors in the Face of Hypertensive Disorders of Pregnancy in Pregnant Women.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Universidad de Antioquia · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

Hypertensive disorders of pregnancy (HDP) are a leading cause of maternal and fetal morbidity and mortality worldwide. The lack of knowledge and self-care behaviors by the pregnant woman in the face of THE could be associated with their appearance. This is a randomized controlled pilot trial type study, with a control group that will receive the usual prenatal care and an intervention group that will additionally receive the nursing intervention to improve knowledge and self-care behaviors in the face of HDP. Each group will include 30 pregnant women, for a total of 60 users. The level of knowledge and self-care behaviors will be assessed before and after the intervention.

Detailed description

Introduction: the World Health Organization (WHO) indicates that HDP are the third leading cause of maternal death worldwide; and in Latin America and the Caribbean they are positioned as the first cause. The evidence has described that limited or non-existent knowledge and the lack of self-care behaviors by the pregnant woman in the face of HDP are important conditions in the incidence of this obstetric complication. In this sense, nursing must design and implement intervention strategies that have a positive impact on knowledge and self-care behaviors in the face of HDP. Objective: to determine the feasibility and acceptability of the "EducaTHE" nursing intervention to improve knowledge and self-care behaviors in the face of hypertensive disorders of pregnancy in pregnant women. Methods: randomized controlled pilot trial experimental study with pregnant women assigned to an intervention group and a control group. The sample will consist of a total of 40 pregnant women, 20 in each of the study groups. The intervention group will receive the usual education of prenatal control. The control group, in addition to the usual prenatal control information, will receive an educational, behavioral and motivational intervention related to HDP and their self-care behaviors. The intervention will be carried out in 4 sessions, on a weekly basis, in a face-to-face and group. In both groups, knowledge and self-care behaviors will be measured before and 4 weeks after the end of the intervention. Randomization: the assignment will be carried out through a simple randomization process, with an intervention/control ratio 1:1, by means of a sequence of random numbers generated by a statistical program. The assignment will be given by one of the researchers who will not perform the intervention, nor the initial or final evaluation. Expected results: feasibility and acceptability of the study in the context of perinatal maternal care

Conditions

Interventions

TypeNameDescription
BEHAVIORALNursing intervention to improve knowledge and self-care behaviors in the face of HDPThe nursing professional will perform 1 session weekly, for 4 weeks, lasting 90 minutes each. The contents that make up each of the sessions are: Session 1. Knowledge about the risk factors, signs and symptoms, maternal and fetal complications of HDP. Session 2. Control over behaviour, positive attitude and family and social support: essential components for conducting self-care behaviour. Session 3. Nutritional recommendations: eating healthy helps prevent or reduce the risk of developing HDP. Recommendations to improve sleep, rest and physical exercise: key routines in my health to prevent or reduce the risk of developing HDP. Session 4. Mental health promotion: managing my stress, anxiety and depression levels help prevent or decrease the risk of HDP

Timeline

Start date
2023-04-10
Primary completion
2023-08-16
Completion
2023-12-28
First posted
2023-05-01
Last updated
2024-05-16

Locations

1 site across 1 country: Colombia

Source: ClinicalTrials.gov record NCT05837962. Inclusion in this directory is not an endorsement.